{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:14:33Z","timestamp":1793463273712,"version":"4.5.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100007028","name":"Leona M. and Harry B. Helmsley Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41591-026-04616-y","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:02:37Z","timestamp":1788253357000},"page":"3385-3395","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Antifungal therapy improves microbiome dynamics in inflammatory bowel disease"],"prefix":"10.1038","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2537-6616","authenticated-orcid":false,"given":"Xiangyu","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1315-019X","authenticated-orcid":false,"given":"Aidan","family":"Conroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsering S.","family":"Ngima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4788-8794","authenticated-orcid":false,"given":"Marissa","family":"Mesko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Morzhanaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars F.","family":"Westblade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Grier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4264-6451","authenticated-orcid":false,"given":"Petra","family":"Bacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy S.","family":"Longman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen J.","family":"Scherl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0884-9749","authenticated-orcid":false,"given":"Iliyan D.","family":"Iliev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"4616_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrgastro.2015.34","volume":"12","author":"AN Ananthakrishnan","year":"2015","unstructured":"Ananthakrishnan, A. N. Epidemiology and risk factors for IBD. Nat. Rev. Gastroenterol. Hepatol. 12, 205\u2013217 (2015).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"4616_CR2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41575-022-00593-y","volume":"19","author":"M Agrawal","year":"2022","unstructured":"Agrawal, M., Allin, K. H., Petralia, F., Colombel, J.-F. & Jess, T. Multiomics to elucidate inflammatory bowel disease risk factors and pathways. Nat. Rev. Gastroenterol. Hepatol. 19, 399\u2013409 (2022).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"4616_CR3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/ecco-jcc\/jjz131","volume":"14","author":"J-F Colombel","year":"2020","unstructured":"Colombel, J.-F., D\u2019haens, G., Lee, W.-J., Petersson, J. & Panaccione, R. Outcomes and strategies to support a treat-to-target approach in inflammatory bowel disease: a systematic review. J. Crohns Colitis 14, 254\u2013266 (2020).","journal-title":"J. Crohns Colitis"},{"key":"4616_CR4","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1146\/annurev-immunol-030409-101225","volume":"28","author":"A Kaser","year":"2010","unstructured":"Kaser, A., Zeissig, S. & Blumberg, R. S. Inflammatory bowel disease. Annu. Rev. Immunol. 28, 573\u2013621 (2010).","journal-title":"Annu. Rev. Immunol."},{"key":"4616_CR5","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1053\/j.gastro.2020.09.056","volume":"160","author":"M Lee","year":"2021","unstructured":"Lee, M. & Chang, E. B. Inflammatory bowel diseases (IBD) and the microbiome-searching the crime scene for clues. Gastroenterology 160, 524\u2013537 (2021).","journal-title":"Gastroenterology"},{"key":"4616_CR6","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","volume":"569","author":"J Lloyd-Price","year":"2019","unstructured":"Lloyd-Price, J. et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature 569, 655\u2013662 (2019).","journal-title":"Nature"},{"key":"4616_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","volume":"17","author":"A Lavelle","year":"2020","unstructured":"Lavelle, A. & Sokol, H. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat. Rev. Gastroenterol. Hepatol. 17, 223\u2013237 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"4616_CR8","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41579-025-01163-0","volume":"23","author":"ID Iliev","year":"2025","unstructured":"Iliev, I. D., Ananthakrishnan, A. N. & Guo, C.-J. Microbiota in inflammatory bowel disease: mechanisms of disease and therapeutic opportunities. Nat. Rev. Microbiol. 23, 509\u2013524 (2025).","journal-title":"Nat. Rev. Microbiol."},{"key":"4616_CR9","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01250-16","volume":"7","author":"G Hoarau","year":"2016","unstructured":"Hoarau, G. et al. Bacteriome and mycobiome interactions underscore microbial dysbiosis in familial Crohn\u2019s disease. mBio 7, e01250-16 (2016).","journal-title":"mBio"},{"key":"4616_CR10","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1136\/gutjnl-2022-327811","volume":"71","author":"S Kedia","year":"2022","unstructured":"Kedia, S., Virmani, S. & KV, S. Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: a randomised controlled trial. Gut 71, 2401\u20132413 (2022).","journal-title":"Gut"},{"key":"4616_CR11","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/S0140-6736(17)30182-4","volume":"389","author":"S Paramsothy","year":"2017","unstructured":"Paramsothy, S. et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet 389, 1218\u20131228 (2017).","journal-title":"Lancet"},{"key":"4616_CR12","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/ecco-jcc\/jjx063","volume":"11","author":"S Paramsothy","year":"2017","unstructured":"Paramsothy, S. et al. Faecal microbiota transplantation for inflammatory bowel disease: a systematic review and meta-analysis. J. Crohns Colitis 11, 1180\u20131199 (2017).","journal-title":"J. Crohns Colitis"},{"key":"4616_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-020-0792-5","volume":"8","author":"H Sokol","year":"2020","unstructured":"Sokol, H. et al. Fecal microbiota transplantation to maintain remission in Crohn\u2019s disease: a pilot randomized controlled study. Microbiome 8, 12 (2020).","journal-title":"Microbiome"},{"key":"4616_CR14","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1136\/gutjnl-2015-310746","volume":"66","author":"H Sokol","year":"2017","unstructured":"Sokol, H. et al. Fungal microbiota dysbiosis in IBD. Gut 66, 1039\u20131048 (2017).","journal-title":"Gut"},{"key":"4616_CR15","doi-asserted-by":"publisher","first-page":"5121","DOI":"10.1016\/j.cell.2024.08.016","volume":"187","author":"ID Iliev","year":"2024","unstructured":"Iliev, I. D. et al. Focus on fungi. Cell 187, 5121\u20135127 (2024).","journal-title":"Cell"},{"key":"4616_CR16","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1126\/science.abd0919","volume":"371","author":"U Jain","year":"2021","unstructured":"Jain, U. et al. Debaryomyces is enriched in Crohn\u2019s disease intestinal tissue and impairs healing in mice. Science 371, 1154\u20131159 (2021).","journal-title":"Science"},{"key":"4616_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.chom.2019.01.007","volume":"25","author":"JJ Limon","year":"2019","unstructured":"Limon, J. J. et al. Malassezia is associated with Crohn\u2019s disease and exacerbates colitis in mouse models. Cell Host Microbe 25, 377\u2013388 (2019).","journal-title":"Cell Host Microbe"},{"key":"4616_CR18","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.chom.2020.03.006","volume":"27","author":"I Leonardi","year":"2020","unstructured":"Leonardi, I. et al. Fungal trans-kingdom dynamics linked to responsiveness to fecal microbiota transplantation (FMT) therapy in ulcerative colitis. Cell Host Microbe 27, 823\u2013829 (2020).","journal-title":"Cell Host Microbe"},{"key":"4616_CR19","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41586-021-03722-w","volume":"596","author":"KS Ost","year":"2021","unstructured":"Ost, K. S. et al. Adaptive immunity induces mutualism between commensal eukaryotes. Nature 596, 114\u2013118 (2021).","journal-title":"Nature"},{"key":"4616_CR20","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1038\/s41564-021-00983-z","volume":"6","author":"I Doron","year":"2021","unstructured":"Doron, I. et al. Mycobiota-induced IgA antibodies regulate fungal commensalism in the gut and are dysregulated in Crohn\u2019s disease. Nat. Microbiol. 6, 1493\u20131504 (2021).","journal-title":"Nat. Microbiol."},{"key":"4616_CR21","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1126\/science.abq3178","volume":"381","author":"JF Pierre","year":"2023","unstructured":"Pierre, J. F. et al. Peptide YY: a Paneth cell antimicrobial peptide that maintains Candida gut commensalism. Science 381, 502\u2013508 (2023).","journal-title":"Science"},{"key":"4616_CR22","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41586-022-04502-w","volume":"603","author":"XV Li","year":"2022","unstructured":"Li, X. V. et al. Immune regulation by fungal strain diversity in inflammatory bowel disease. Nature 603, 672\u2013678 (2022).","journal-title":"Nature"},{"key":"4616_CR23","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00645-17","volume":"86","author":"JP Richardson","year":"2018","unstructured":"Richardson, J. P. et al. Candidalysin drives epithelial signaling, neutrophil recruitment, and immunopathology at the vaginal mucosa. Infect. Immun. 86, e00645-17 (2018).","journal-title":"Infect. Immun."},{"key":"4616_CR24","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1038\/s41591-023-02556-5","volume":"29","author":"GR Martini","year":"2023","unstructured":"Martini, G. R. et al. Selection of cross-reactive T cells by commensal and food-derived yeasts drives cytotoxic TH1 cell responses in Crohn\u2019s disease. Nat. Med. 29, 2602\u20132614 (2023).","journal-title":"Nat. Med."},{"key":"4616_CR25","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1053\/j.gastro.2020.03.007","volume":"159","author":"J Torres","year":"2020","unstructured":"Torres, J. et al. Serum biomarkers identify patients who will develop inflammatory bowel diseases up to 5 years before diagnosis. Gastroenterology 159, 96\u2013104 (2020).","journal-title":"Gastroenterology"},{"key":"4616_CR26","first-page":"7","volume":"91","author":"D Lisciandrano","year":"1996","unstructured":"Lisciandrano, D. et al. Prevalence of oral lesions in inflammatory bowel disease. Am. J. Gastroenterol. 91, 7\u201310 (1996).","journal-title":"Am. J. Gastroenterol."},{"key":"4616_CR27","unstructured":"Malik, T. F. & Aurelio, D. M. Extraintestinal manifestations of inflammatory bowel disease. In StatPearls https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK568797\/ (StatPearls Publishing, 2026)."},{"key":"4616_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/MPG.0000000000003302","volume":"74","author":"MA Shazib","year":"2022","unstructured":"Shazib, M. A., Byrd, K. M. & Gulati, A. S. Diagnosis and management of oral extraintestinal manifestations of pediatric inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 74, 7\u201312 (2022).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"4616_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04787-4","volume":"9","author":"J Ropars","year":"2018","unstructured":"Ropars, J. et al. Gene flow contributes to diversification of the major fungal pathogen Candida albicans. Nat. Commun. 9, 2253 (2018).","journal-title":"Nat. Commun."},{"key":"4616_CR30","doi-asserted-by":"publisher","first-page":"E8688","DOI":"10.1073\/pnas.1806002115","volume":"115","author":"IV Ene","year":"2018","unstructured":"Ene, I. V. et al. Global analysis of mutations driving microevolution of a heterozygous diploid fungal pathogen. Proc. Natl Acad. Sci. USA 115, E8688\u2013E8697 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4616_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41591-019-0709-7","volume":"26","author":"B Zhai","year":"2020","unstructured":"Zhai, B. et al. High-resolution mycobiota analysis reveals dynamic intestinal translocation preceding invasive candidiasis. Nat. Med. 26, 59\u201364 (2020).","journal-title":"Nat. Med."},{"key":"4616_CR32","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41577-022-00826-w","volume":"23","author":"MS Lionakis","year":"2023","unstructured":"Lionakis, M. S., Drummond, R. A. & Hohl, T. M. Immune responses to human fungal pathogens and therapeutic prospects. Nat. Rev. Immunol. 23, 433\u2013452 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"4616_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-017-0373-4","volume":"5","author":"AK Nash","year":"2017","unstructured":"Nash, A. K. et al. The gut mycobiome of the Human Microbiome Project healthy cohort. Microbiome 5, 153 (2017).","journal-title":"Microbiome"},{"key":"4616_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43380-2","volume":"14","author":"X Fan","year":"2023","unstructured":"Fan, X. et al. Tandem gene duplications contributed to high-level azole resistance in a rapidly expanding Candida tropicalis population. Nat. Commun. 14, 8369 (2023).","journal-title":"Nat. Commun."},{"key":"4616_CR35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10096-005-0066-y","volume":"25","author":"SM Arend","year":"2006","unstructured":"Arend, S. M., Kuijper, E. J., Vaal, B. J., Fijter, J. W. & Wout, J. W. Successful treatment of fungus balls due to fluconazole-resistant Candida sake obstructing ureter stents in a renal transplant patient. Eur. J. Clin. Microbiol. Infect. Dis. 25, 43\u201345 (2006).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"4616_CR36","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1053\/j.gastro.2022.07.004","volume":"163","author":"H Leibovitzh","year":"2022","unstructured":"Leibovitzh, H. et al. Altered gut microbiome composition and function are associated with gut barrier dysfunction in healthy relatives of patients with Crohn\u2019s disease. Gastroenterology 163, 1364\u20131376 (2022).","journal-title":"Gastroenterology"},{"key":"4616_CR37","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/nm.3871","volume":"21","author":"D Fan","year":"2015","unstructured":"Fan, D. et al. Activation of HIF-1\u03b1 and LL-37 by commensal bacteria inhibits Candida albicans colonization. Nat. Med. 21, 808\u2013814 (2015).","journal-title":"Nat. Med."},{"key":"4616_CR38","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.add2120","volume":"9","author":"H Morita","year":"2023","unstructured":"Morita, H. et al. Bacteroides uniformis and its preferred substrate, \u03b1-cyclodextrin, enhance endurance exercise performance in mice and human males. Sci. Adv. 9, eadd2120 (2023).","journal-title":"Sci. Adv."},{"key":"4616_CR39","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.chom.2022.01.002","volume":"30","author":"T Dapa","year":"2022","unstructured":"Dapa, T., Ramiro, R. S., Pedro, M. F., Gordo, I. & Xavier, K. B. Diet leaves a genetic signature in a keystone member of the gut microbiota. Cell Host Microbe 30, 183\u2013199 (2022).","journal-title":"Cell Host Microbe"},{"key":"4616_CR40","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/ni.3400","volume":"17","author":"ND Mathewson","year":"2016","unstructured":"Mathewson, N. D. et al. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat. Immunol. 17, 505\u2013513 (2016).","journal-title":"Nat. Immunol."},{"key":"4616_CR41","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/nature09128","volume":"465","author":"SE Alvarez","year":"2010","unstructured":"Alvarez, S. E. et al. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature 465, 1084\u20131088 (2010).","journal-title":"Nature"},{"key":"4616_CR42","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cmet.2021.06.006","volume":"33","author":"CD Green","year":"2021","unstructured":"Green, C. D., Maceyka, M., Cowart, L. A. & Spiegel, S. Sphingolipids in metabolic disease: the good, the bad, and the unknown. Cell Metab. 33, 1293\u20131306 (2021).","journal-title":"Cell Metab."},{"key":"4616_CR43","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/ni.2228","volume":"13","author":"H Wen","year":"2012","unstructured":"Wen, H., Ting, J. P.-Y. & O\u2019Neill, L. A. J. A role for the NLRP3 inflammasome in metabolic diseases\u2014did Warburg miss inflammation?. Nat. Immunol. 13, 352\u2013357 (2012).","journal-title":"Nat. Immunol."},{"key":"4616_CR44","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature13479","volume":"510","author":"CN Serhan","year":"2014","unstructured":"Serhan, C. N. Pro-resolving lipid mediators are leads for resolution physiology. Nature 510, 92\u2013101 (2014).","journal-title":"Nature"},{"key":"4616_CR45","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","volume":"21","author":"SL Collins","year":"2023","unstructured":"Collins, S. L., Stine, J. G., Bisanz, J. E., Okafor, C. D. & Patterson, A. D. Bile acids and the gut microbiota: metabolic interactions and impacts on disease. Nat. Rev. Microbiol. 21, 236\u2013247 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"4616_CR46","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41569-021-00582-9","volume":"18","author":"NA Reilly","year":"2021","unstructured":"Reilly, N. A., Lutgens, E., Kuiper, J., Heijmans, B. T. & Jukema, J. W. Effects of fatty acids on T cell function: role in atherosclerosis. Nat. Rev. Cardiol. 18, 824\u2013837 (2021).","journal-title":"Nat. Rev. Cardiol."},{"key":"4616_CR47","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.immuni.2024.02.014","volume":"57","author":"J Cong","year":"2024","unstructured":"Cong, J. et al. Bile acids modified by the intestinal microbiota promote colorectal cancer growth by suppressing CD8+ T cell effector functions. Immunity 57, 876\u2013889 (2024).","journal-title":"Immunity"},{"key":"4616_CR48","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1136\/gutjnl-2022-327756","volume":"72","author":"H Sun","year":"2023","unstructured":"Sun, H. et al. Gut commensal Parabacteroides distasonis alleviates inflammatory arthritis. Gut 72, 1664\u20131677 (2023).","journal-title":"Gut"},{"key":"4616_CR49","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.chom.2020.12.004","volume":"29","author":"SN Chaudhari","year":"2021","unstructured":"Chaudhari, S. N. et al. A microbial metabolite remodels the gut-liver axis following bariatric surgery. Cell Host Microbe 29, 408\u2013424 (2021).","journal-title":"Cell Host Microbe"},{"key":"4616_CR50","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1093\/ibd\/izy182","volume":"24","author":"L Zhou","year":"2018","unstructured":"Zhou, L. et al. Faecalibacterium prausnitzii produces butyrate to maintain Th17\/Treg balance and to ameliorate colorectal colitis by inhibiting histone deacetylase 1. Inflamm. Bowel Dis. 24, 1926\u20131940 (2018).","journal-title":"Inflamm. Bowel Dis."},{"key":"4616_CR51","doi-asserted-by":"publisher","first-page":"16731","DOI":"10.1073\/pnas.0804812105","volume":"105","author":"H Sokol","year":"2008","unstructured":"Sokol, H. et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl Acad. Sci. USA 105, 16731\u201316736 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4616_CR52","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.chom.2020.01.021","volume":"27","author":"SR Sinha","year":"2020","unstructured":"Sinha, S. R. et al. Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation. Cell Host Microbe 27, 659\u2013670 (2020).","journal-title":"Cell Host Microbe"},{"key":"4616_CR53","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/apt.13445","volume":"43","author":"NS Ding","year":"2016","unstructured":"Ding, N. S., Hart, A. & De Cruz, P. Systematic review: predicting and optimising response to anti-TNF therapy in Crohn\u2019s disease\u2014algorithm for practical management. Aliment Pharmacol. Ther. 43, 30\u201351 (2016).","journal-title":"Aliment Pharmacol. Ther."},{"key":"4616_CR54","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1056\/NEJMoa1602773","volume":"375","author":"BG Feagan","year":"2016","unstructured":"Feagan, B. G. et al. Ustekinumab as induction and maintenance therapy for Crohn\u2019s disease. N. Engl. J. Med. 375, 1946\u20131960 (2016).","journal-title":"N. Engl. J. Med."},{"key":"4616_CR55","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1056\/NEJMoa050516","volume":"353","author":"P Rutgeerts","year":"2005","unstructured":"Rutgeerts, P. et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N. Engl. J. Med. 353, 2462\u20132476 (2005).","journal-title":"N. Engl. J. Med."},{"key":"4616_CR56","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1056\/NEJMoa2207940","volume":"388","author":"G D\u2019Haens","year":"2023","unstructured":"D\u2019Haens, G. et al. Mirikizumab as induction and maintenance therapy for ulcerative colitis. N. Engl. J. Med. 388, 2444\u20132455 (2023).","journal-title":"N. Engl. J. Med."},{"key":"4616_CR57","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S2468-1253(24)00044-X","volume":"9","author":"N Chanchlani","year":"2024","unstructured":"Chanchlani, N. et al. Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn\u2019s disease: 3-year data from the prospective, multicentre PANTS cohort study. Lancet Gastroenterol. Hepatol. 9, 521\u2013538 (2024).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"4616_CR58","first-page":"107","volume":"60","author":"M Zwolinska-Wcislo","year":"2009","unstructured":"Zwolinska-Wcislo, M. et al. Effect of Candida colonization on human ulcerative colitis and the healing of inflammatory changes of the colon in the experimental model of colitis ulcerosa. J. Physiol. Pharmacol. 60, 107\u2013118 (2009).","journal-title":"J. Physiol. Pharmacol."},{"key":"4616_CR59","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1097\/MCG.0000000000001609","volume":"56","author":"A Jena","year":"2022","unstructured":"Jena, A. et al. Oral fluconazole therapy in patients with active ulcerative colitis who have detectable Candida in the stool: a double-blind randomized placebo-controlled trial. J. Clin. Gastroenterol. 56, 705\u2013711 (2022).","journal-title":"J. Clin. Gastroenterol."},{"key":"4616_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/jof7050324","volume":"7","author":"B Sendid","year":"2021","unstructured":"Sendid, B. et al. A pilot clinical study on post-operative recurrence provides biological clues for a role of Candida yeasts and fluconazole in Crohn\u2019s disease. J. Fungi (Basel) 7, 324 (2021).","journal-title":"J. Fungi (Basel)"},{"key":"4616_CR61","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1038\/s41587-023-01688-w","volume":"41","author":"A Blanco-M\u00edguez","year":"2023","unstructured":"Blanco-M\u00edguez, A. et al. Extending and improving metagenomic taxonomic profiling with uncharacterized species using MetaPhlAn 4. Nat. Biotechnol. 41, 1633\u20131644 (2023).","journal-title":"Nat. Biotechnol."},{"key":"4616_CR62","doi-asserted-by":"publisher","first-page":"e65088","DOI":"10.7554\/eLife.65088","volume":"10","author":"F Beghini","year":"2021","unstructured":"Beghini, F. et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. Elife 10, e65088 (2021).","journal-title":"Elife"},{"key":"4616_CR63","doi-asserted-by":"publisher","first-page":"7074","DOI":"10.1021\/ac201267k","volume":"83","author":"T Fuhrer","year":"2011","unstructured":"Fuhrer, T., Heer, D., Begemann, B. & Zamboni, N. High-throughput, accurate mass metabolome profiling of cellular extracts by flow injection-time-of-flight mass spectrometry. Anal. Chem. 83, 7074\u20137080 (2011).","journal-title":"Anal. Chem."},{"key":"4616_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00946-8","volume":"7","author":"X Pan","year":"2022","unstructured":"Pan, X. et al. Identifying a confused cell identity for esophageal squamous cell carcinoma. Sig. Transduct. Target. Ther. 7, 122 (2022).","journal-title":"Sig. Transduct. Target. Ther."},{"key":"4616_CR65","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1126\/science.1205438","volume":"334","author":"DN Reshef","year":"2011","unstructured":"Reshef, D. N. et al. Detecting novel associations in large data sets. Science 334, 1518\u20131524 (2011).","journal-title":"Science"},{"key":"4616_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-024-05883-7","volume":"25","author":"D Francis","year":"2024","unstructured":"Francis, D. & Sun, F. A comparative analysis of mutual information methods for pairwise relationship detection in metagenomic data. BMC Bioinformatics 25, 266 (2024).","journal-title":"BMC Bioinformatics"},{"key":"4616_CR67","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ab.2018.12.008","volume":"567","author":"Y You","year":"2019","unstructured":"You, Y. et al. Evaluation of metabolite-microbe correlation detection methods. Anal. Biochem. 567, 106\u2013111 (2019).","journal-title":"Anal. Biochem."},{"key":"4616_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e41184","volume":"11","author":"Z Fan","year":"2025","unstructured":"Fan, Z. et al. ISCAZIM: integrated statistical correlation analysis for zero-inflated microbiome data. Heliyon 11, e41184 (2025).","journal-title":"Heliyon"},{"key":"4616_CR69","doi-asserted-by":"publisher","first-page":"4419","DOI":"10.1128\/JCM.42.10.4419-4431.2004","volume":"42","author":"MA Pfaller","year":"2004","unstructured":"Pfaller, M. A. & Diekema, D. J. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J. Clin. Microbiol. 42, 4419\u20134431 (2004).","journal-title":"J. Clin. Microbiol."},{"key":"4616_CR70","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10096-006-0093-3","volume":"25","author":"A Adler","year":"2006","unstructured":"Adler, A. et al. Exserohilum: an emerging human pathogen. Eur. J. Clin. Microbiol. Infect. Dis. 25, 247\u2013253 (2006).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"4616_CR71","doi-asserted-by":"publisher","unstructured":"American Academy of Microbiology. One Health: Fungal Pathogens of Humans, Animals, and Plants: Report on an American Academy of Microbiology Colloquium Held in Washington, DC, on October 18, 2017 https:\/\/doi.org\/10.1128\/AAMCol.18Oct.2017 (American Society for Microbiology, 2019).","DOI":"10.1128\/AAMCol.18Oct.2017"},{"key":"4616_CR72","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41564-022-01112-0","volume":"7","author":"A Rokas","year":"2022","unstructured":"Rokas, A. Evolution of the human pathogenic lifestyle in fungi. Nat. Microbiol. 7, 607\u2013619 (2022).","journal-title":"Nat. Microbiol."},{"key":"4616_CR73","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1016\/j.cell.2024.04.043","volume":"187","author":"Q Yan","year":"2024","unstructured":"Yan, Q. et al. A genomic compendium of cultivated human gut fungi characterizes the gut mycobiome and its relevance to common diseases. Cell 187, 2969\u20132989 (2024).","journal-title":"Cell"},{"key":"4616_CR74","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41586-019-1065-y","volume":"568","author":"D Zeevi","year":"2019","unstructured":"Zeevi, D. et al. Structural variation in the gut microbiome associates with host health. Nature 568, 43\u201348 (2019).","journal-title":"Nature"},{"key":"4616_CR75","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41577-024-01014-8","volume":"24","author":"ER Mann","year":"2024","unstructured":"Mann, E. R., Lam, Y. K. & Uhlig, H. H. Short-chain fatty acids: linking diet, the microbiome and immunity. Nat. Rev. Immunol. 24, 577\u2013595 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"4616_CR76","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","volume":"19","author":"Y Fan","year":"2021","unstructured":"Fan, Y. & Pedersen, O. Gut microbiota in human metabolic health and disease. Nat. Rev. Microbiol. 19, 55\u201371 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"4616_CR77","doi-asserted-by":"publisher","unstructured":"Pan, X. Antifungal therapy improves microbiome dynamics in inflammatory bowel disease, v1. Zenodo https:\/\/doi.org\/10.5281\/zenodo.21072154 (2026).","DOI":"10.5281\/zenodo.21072154"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04616-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04616-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04616-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:02:15Z","timestamp":1791194535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04616-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":77,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["4616"],"URL":"https:\/\/doi.org\/10.1038\/s41591-026-04616-y","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"19 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}